Position in ABBV
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$3,863,428
+$508,863 QoQ
Shares Held
15,353
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#1,479
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. ABBV ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,571 | $9,080,885 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
15,353 | $3,863,428 | |
| 3 | JNJ |
Johnson & Johnson
|
15,184 | $3,856,280 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,556 | $1,998,945 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
22,434 | $1,292,646 | |
| 6 | AMGN |
Amgen Inc
|
3,253 | $1,177,976 | |
| 7 | AZN |
Astrazeneca PLC
|
5,776 | $1,095,244 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,271 | $792,278 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,863,428 | 15,353 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $3,354,565 | 15,424 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $3,406,556 | 14,909 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $3,435,590 | 14,838 | Shares | Defined | 2025-10-06 | |
| 2025-06-30 | $2,776,875 | 14,960 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $3,150,552 | 15,037 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $2,335,155 | 13,141 | Shares | Defined | 2025-01-16 | |
| 2024-09-30 | $2,539,395 | 12,859 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $2,180,019 | 12,710 | Shares | Defined | 2024-07-24 | |
| 2024-03-31 | $2,341,623 | 12,859 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $2,591,408 | 16,722 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $2,455,912 | 16,476 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $2,120,784 | 15,741 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $2,664,188 | 16,717 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $2,659,777 | 16,458 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $2,641,387 | 19,681 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $3,271,344 | 21,359 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,656,228 | 22,554 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $2,932,764 | 21,660 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,345,417 | 21,743 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,428,743 | 21,562 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,249,028 | 20,782 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,225,826 | 20,773 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,717,815 | 19,612 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,139,538 | 21,792 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,493,095 | 19,597 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||